Simplify Logo

Full-Time

Sr. Medical Ambassador / Medical Science Liaison

Msl, New York Metro

Confirmed live in the last 24 hours

Tarsus Pharamceuticals

Tarsus Pharamceuticals

201-500 employees

Biopharmaceuticals for eye and infectious diseases

Hardware
Biotechnology

Compensation Overview

$158.2k - $221.6kAnnually

+ Bonus + Stock Equity

Mid, Senior

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • Doctorate of optometry, or MD, PharmD, PhD with eye care expertise required.
  • 3+ years of experience as a medical science liaison in eye care is preferred; or 3+ years of clinical experience in eyecare with at least one year of industry experience or 7 + years of clinical practice in eyecare.
  • Strong emotional intelligence and presentation skills.
  • Ability to plan, organize, manage, and prioritize workload proactively in a fast-paced environment.
  • Ability to navigate systems and processes including Microsoft Office and customer relationship management software, work independently, and be self-motivated.
  • Ability to collect actionable insights and critically analyze data.
  • Ability to influence and collaborate with peers.
  • Strong verbal and written communication skills to convey technical and clinical information.
Responsibilities
  • Manage key opinion leader (KOL) optometrists and ophthalmologists in a designated region, ensuring compliant conduct per PhRMA and Tarsus guidelines.
  • Be the primary medical affairs KOL point of contact for day to day needs and peer-based scientific exchange, adhering to our Tarsus scientific platform; engagements may include both virtual and live interactions.
  • Collect actionable insights from field scientific exchange, prioritize and collate these insights to shape medical strategy.
  • Provide whole practice education to optometric and ophthalmic centers.
  • Provide resources to facilitate disease state education in Optometry schools and Ophthalmology residency programs.
  • Instruct customers (upon request) on investigator initiated trial and medical information procedures.
  • Compliantly identify and recommend KOLs for a variety of projects (including advisory boards, medical education initiatives, training, publications, special projects, clinical trials, business development evaluations) based on expertise, interests, and competencies.
  • Plan KOL engagements and schedule and attend scientific sessions at local, regional and national medical meetings as needed.
  • Liaise with local and regional optometric and ophthalmic medical societies.
  • Present scientific evidence to the payer community.
  • Provide leadership and expertise on medical affairs projects and initiatives.
  • Participate in continual optimization of training, insights gathering and field medical processes.
  • Host local disease state scientific exchanges and “lid+lash labs.”
  • Participate in compliant and collaborative engagements with cross-functional team members including training and KOL meetings.
  • Provide clinical trial support as needed and determine by the clinical development team.
  • Manage territory budget, metrics, KOL mapping and CRM entries.
Tarsus Pharamceuticals

Tarsus Pharamceuticals

View

Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution used to treat Demodex Blepharitis, a condition affecting the eyelids. The company also has a pipeline of potential treatments for other conditions, including Lyme Disease Prevention and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong commitment to ethical practices and compliance. The goal of Tarsus Pharmaceuticals is to provide effective medical treatments that improve patient outcomes in areas where there are currently few options.

Company Stage

IPO

Total Funding

$610.6M

Headquarters

Irvine, California

Founded

2017

Growth & Insights
Headcount

6 month growth

5%

1 year growth

12%

2 year growth

192%
Simplify Jobs

Simplify's Take

What believers are saying

  • Securing $200 million in non-dilutive financing from Pharmakon Advisors strengthens Tarsus's financial position, enabling further R&D and market expansion.
  • Positive Phase 2a trial results for TP-05 for Lyme Disease prevention indicate promising future product offerings and potential market growth.
  • Recognition through awards like the Zero to Launch Award highlights Tarsus's innovative approach and successful commercialization strategies.

What critics are saying

  • The biopharmaceutical market is highly competitive and capital-intensive, requiring continuous innovation and substantial investment to maintain a competitive edge.
  • Dependence on the success of a limited number of products, such as XDEMVY, makes the company vulnerable to market fluctuations and regulatory changes.

What makes Tarsus Pharamceuticals unique

  • Tarsus Pharmaceuticals focuses on high unmet medical needs in eye care and infectious diseases, setting it apart from competitors with broader but less specialized portfolios.
  • Their flagship product, XDEMVY, is FDA-approved for treating Demodex Blepharitis, a niche condition with limited treatment options, giving them a unique market position.
  • The company's commitment to ethical operations and robust compliance programs ensures trust and reliability among healthcare providers and patients.